Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cathepsin B | 11 | 2022 | 35 | 5.620 |
Why?
|
| Macrophages | 17 | 2025 | 529 | 4.960 |
Why?
|
| HIV Infections | 18 | 2025 | 2586 | 2.860 |
Why?
|
| HIV-1 | 16 | 2025 | 755 | 2.860 |
Why?
|
| Proteomics | 11 | 2026 | 378 | 2.570 |
Why?
|
| Cannabinoids | 3 | 2025 | 73 | 2.320 |
Why?
|
| AIDS Dementia Complex | 8 | 2019 | 116 | 2.320 |
Why?
|
| Cystatin B | 6 | 2022 | 11 | 1.700 |
Why?
|
| Receptor, Cannabinoid, CB2 | 2 | 2025 | 38 | 1.620 |
Why?
|
| Neurons | 7 | 2022 | 1263 | 1.570 |
Why?
|
| Proteome | 5 | 2026 | 152 | 1.210 |
Why?
|
| Apoptosis | 10 | 2025 | 1568 | 1.110 |
Why?
|
| Cognition Disorders | 6 | 2017 | 243 | 0.960 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2025 | 108 | 0.900 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2025 | 105 | 0.890 |
Why?
|
| Autophagy | 1 | 2025 | 140 | 0.850 |
Why?
|
| Phosphoproteins | 1 | 2025 | 206 | 0.830 |
Why?
|
| MAP Kinase Signaling System | 1 | 2025 | 196 | 0.810 |
Why?
|
| Virus Replication | 5 | 2022 | 318 | 0.780 |
Why?
|
| Monocytes | 6 | 2013 | 277 | 0.720 |
Why?
|
| Tandem Mass Spectrometry | 5 | 2026 | 241 | 0.720 |
Why?
|
| Membrane Proteins | 1 | 2025 | 561 | 0.710 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 719 | 0.700 |
Why?
|
| Antioxidants | 2 | 2018 | 443 | 0.690 |
Why?
|
| Humans | 31 | 2025 | 43102 | 0.630 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2021 | 117 | 0.620 |
Why?
|
| Endoribonucleases | 1 | 2019 | 25 | 0.600 |
Why?
|
| Ethylenediamines | 1 | 2018 | 8 | 0.580 |
Why?
|
| Receptors, sigma | 1 | 2018 | 16 | 0.580 |
Why?
|
| Cocaine | 2 | 2018 | 251 | 0.560 |
Why?
|
| Female | 22 | 2025 | 24698 | 0.540 |
Why?
|
| Anabolic Agents | 1 | 2017 | 20 | 0.530 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 228 | 0.520 |
Why?
|
| Hypothalamus | 1 | 2017 | 120 | 0.510 |
Why?
|
| Androgens | 1 | 2017 | 106 | 0.500 |
Why?
|
| Interferon-beta | 1 | 2016 | 9 | 0.490 |
Why?
|
| STAT1 Transcription Factor | 1 | 2016 | 34 | 0.480 |
Why?
|
| Cells, Cultured | 5 | 2019 | 1621 | 0.470 |
Why?
|
| Oxidative Stress | 4 | 2025 | 1003 | 0.470 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 209 | 0.430 |
Why?
|
| Cell Line | 4 | 2019 | 1410 | 0.410 |
Why?
|
| Cocaine-Related Disorders | 1 | 2014 | 102 | 0.410 |
Why?
|
| HIV Seropositivity | 2 | 2013 | 196 | 0.410 |
Why?
|
| Microglia | 1 | 2015 | 208 | 0.390 |
Why?
|
| NF-kappa B | 2 | 2025 | 358 | 0.360 |
Why?
|
| Placenta | 2 | 2022 | 117 | 0.340 |
Why?
|
| Cerebrospinal Fluid | 2 | 2007 | 20 | 0.340 |
Why?
|
| Flow Cytometry | 3 | 2019 | 411 | 0.330 |
Why?
|
| Lysosomes | 2 | 2024 | 86 | 0.290 |
Why?
|
| HIV Core Protein p24 | 2 | 2018 | 12 | 0.290 |
Why?
|
| Phosphorylation | 2 | 2025 | 986 | 0.290 |
Why?
|
| Catalase | 1 | 2008 | 110 | 0.280 |
Why?
|
| Glutathione Peroxidase | 1 | 2008 | 112 | 0.280 |
Why?
|
| Caspase 3 | 2 | 2019 | 227 | 0.280 |
Why?
|
| Superoxide Dismutase | 1 | 2008 | 158 | 0.280 |
Why?
|
| Culture Media, Conditioned | 2 | 2019 | 49 | 0.270 |
Why?
|
| Cell Line, Tumor | 4 | 2025 | 2676 | 0.270 |
Why?
|
| Up-Regulation | 2 | 2025 | 536 | 0.270 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2018 | 138 | 0.250 |
Why?
|
| Adult | 12 | 2024 | 13872 | 0.250 |
Why?
|
| Cohort Studies | 5 | 2017 | 1759 | 0.250 |
Why?
|
| Pregnancy | 2 | 2022 | 1772 | 0.240 |
Why?
|
| Anti-Anxiety Agents | 1 | 2026 | 19 | 0.240 |
Why?
|
| Phagosomes | 1 | 2025 | 33 | 0.230 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2025 | 16 | 0.230 |
Why?
|
| Blotting, Western | 3 | 2017 | 883 | 0.220 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2025 | 65 | 0.220 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2025 | 128 | 0.220 |
Why?
|
| Blood-Brain Barrier | 2 | 2019 | 173 | 0.220 |
Why?
|
| Cisplatin | 1 | 2025 | 98 | 0.220 |
Why?
|
| Drosophila melanogaster | 1 | 2026 | 193 | 0.210 |
Why?
|
| Middle Aged | 9 | 2024 | 12222 | 0.210 |
Why?
|
| Cystatin C | 2 | 2015 | 25 | 0.210 |
Why?
|
| Exocytosis | 1 | 2024 | 49 | 0.210 |
Why?
|
| Blood Proteins | 1 | 2024 | 77 | 0.210 |
Why?
|
| Plant Extracts | 1 | 2026 | 302 | 0.190 |
Why?
|
| Hippocampus | 2 | 2019 | 594 | 0.190 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2025 | 307 | 0.180 |
Why?
|
| Analysis of Variance | 2 | 2017 | 575 | 0.180 |
Why?
|
| Profilins | 1 | 2022 | 2 | 0.180 |
Why?
|
| Puerto Rico | 3 | 2024 | 1413 | 0.180 |
Why?
|
| Serum Amyloid P-Component | 1 | 2022 | 21 | 0.180 |
Why?
|
| Chromatography, Liquid | 2 | 2026 | 182 | 0.180 |
Why?
|
| Fibrinogen | 1 | 2021 | 24 | 0.180 |
Why?
|
| Mice | 4 | 2025 | 6644 | 0.180 |
Why?
|
| Transfection | 2 | 2016 | 532 | 0.170 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2021 | 78 | 0.170 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 3 | 2010 | 78 | 0.170 |
Why?
|
| Ovarian Neoplasms | 1 | 2025 | 415 | 0.170 |
Why?
|
| Young Adult | 2 | 2024 | 5080 | 0.160 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 131 | 0.160 |
Why?
|
| Viral Load | 3 | 2013 | 348 | 0.160 |
Why?
|
| Cytokines | 1 | 2024 | 678 | 0.160 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2012 | 166 | 0.160 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2019 | 8 | 0.150 |
Why?
|
| Synaptophysin | 1 | 2019 | 6 | 0.150 |
Why?
|
| Neuropsychological Tests | 2 | 2013 | 284 | 0.150 |
Why?
|
| Histidine | 1 | 2019 | 43 | 0.150 |
Why?
|
| Mice, Inbred ICR | 1 | 2018 | 44 | 0.150 |
Why?
|
| Reactive Nitrogen Species | 1 | 2018 | 10 | 0.140 |
Why?
|
| Morpholines | 1 | 2018 | 72 | 0.140 |
Why?
|
| Transcription Factors | 1 | 2022 | 735 | 0.140 |
Why?
|
| Animals | 5 | 2026 | 16992 | 0.130 |
Why?
|
| Microwaves | 1 | 2017 | 29 | 0.130 |
Why?
|
| Longitudinal Studies | 2 | 2013 | 1063 | 0.130 |
Why?
|
| Magnetics | 1 | 2017 | 43 | 0.130 |
Why?
|
| Inflammation | 1 | 2022 | 758 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2025 | 1019 | 0.120 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2015 | 229 | 0.120 |
Why?
|
| Signal Transduction | 3 | 2026 | 2157 | 0.120 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 934 | 0.120 |
Why?
|
| Neuronal Plasticity | 1 | 2017 | 126 | 0.120 |
Why?
|
| Apolipoprotein C-III | 1 | 2015 | 7 | 0.120 |
Why?
|
| Synapses | 1 | 2017 | 185 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 532 | 0.110 |
Why?
|
| Protein Transport | 1 | 2016 | 296 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 196 | 0.110 |
Why?
|
| Cell Nucleus | 1 | 2016 | 383 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 1124 | 0.110 |
Why?
|
| Nervous System | 1 | 2014 | 32 | 0.100 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 436 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 458 | 0.100 |
Why?
|
| Male | 4 | 2024 | 23409 | 0.100 |
Why?
|
| Basal Ganglia | 1 | 2012 | 21 | 0.090 |
Why?
|
| Intracellular Space | 1 | 2012 | 37 | 0.090 |
Why?
|
| DNA, Viral | 1 | 2013 | 311 | 0.090 |
Why?
|
| Lymphocytes | 2 | 2013 | 124 | 0.090 |
Why?
|
| Aged | 1 | 2024 | 8214 | 0.090 |
Why?
|
| Immunologic Techniques | 1 | 2010 | 12 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 1070 | 0.080 |
Why?
|
| Peroxiredoxins | 1 | 2010 | 11 | 0.080 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 102 | 0.080 |
Why?
|
| Chromatography, Affinity | 1 | 2010 | 68 | 0.080 |
Why?
|
| Peroxidase | 1 | 2010 | 57 | 0.080 |
Why?
|
| Free Radical Scavengers | 1 | 2010 | 64 | 0.080 |
Why?
|
| Brain | 1 | 2018 | 1472 | 0.080 |
Why?
|
| Thioredoxins | 1 | 2010 | 41 | 0.080 |
Why?
|
| Disease Progression | 1 | 2013 | 667 | 0.080 |
Why?
|
| Mass Spectrometry | 2 | 2007 | 280 | 0.080 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 3156 | 0.070 |
Why?
|
| Confidence Intervals | 1 | 2008 | 162 | 0.070 |
Why?
|
| Cognition | 1 | 2012 | 473 | 0.070 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 1542 | 0.070 |
Why?
|
| Receptors, CCR5 | 1 | 2007 | 64 | 0.070 |
Why?
|
| Receptors, CXCR4 | 1 | 2007 | 74 | 0.060 |
Why?
|
| Virulence | 1 | 2007 | 246 | 0.060 |
Why?
|
| Glioma | 1 | 2007 | 96 | 0.060 |
Why?
|
| Phenotype | 1 | 2007 | 780 | 0.050 |
Why?
|
| Drosophila Proteins | 1 | 2026 | 188 | 0.050 |
Why?
|
| Protein Array Analysis | 1 | 2004 | 27 | 0.050 |
Why?
|
| Mice, Nude | 1 | 2025 | 408 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2025 | 239 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2025 | 347 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 704 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2025 | 456 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2025 | 386 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2008 | 2544 | 0.040 |
Why?
|
| United States | 1 | 2013 | 5205 | 0.040 |
Why?
|
| Smoking | 1 | 2007 | 1024 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2025 | 968 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2025 | 1455 | 0.040 |
Why?
|
| Oxygen Isotopes | 1 | 2015 | 5 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2013 | 64 | 0.030 |
Why?
|
| Complement C3 | 1 | 2007 | 16 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2007 | 197 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2007 | 201 | 0.020 |
Why?
|
| Hawaii | 1 | 2013 | 2011 | 0.020 |
Why?
|
| Wechsler Scales | 1 | 2006 | 7 | 0.020 |
Why?
|
| Women's Health | 1 | 2007 | 160 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2007 | 182 | 0.020 |
Why?
|
| Memory | 1 | 2006 | 174 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 1180 | 0.010 |
Why?
|
| Prevalence | 1 | 2006 | 1612 | 0.010 |
Why?
|